After discovering that scientists can be injectable are effective treatment, people with various food allergies can have more treatment options.
The US researcher team found that O’Malizumab, a drug available, is better than oral immunotherapy when it prevents patients with severe food allergies.
According to the food standard agency, about 6%of British adults suffer from food allergies, and peanuts and wooden nuts such as hazel cancer, walnuts and almonds are likely to cause allergic reactions.
Many NHS hospitals joined last year. ‘Miracle’ £ 25m test that watched children enjoy food It would have caused anaphylaxis before or oral immunotherapy.
The 11 -year -old Thomas Farmer now allows you to eat six peanuts a day after joining the NHS oral immunotherapy test. File Photo: University Hospital Southampton NHS FOUNDATION
However, in a new study led by Johns Hopkins Children’s Center, 36%of the participants who received new injections were able to eat about eight peanuts and two other food allergens until the end of the test.
Oral immunotherapy gradually consumes dose foods to reduce allergic reactions.
On the other hand, O’Malicumab binds to an antibody called immunoglobulin E in the blood to prevent immune cells in charge of allergic reactions.
This shows that the cells make it less sensitive to all allergen’s stimuli.
During the study, 177 young and three adults were divided into groups.
Read in more detail in science, climate and technology:
Tiktok, Reddit and Imgur have investigated the use of children’s data.
Look at Professor Brian Cox’s speech from the Space Committee
Secondly, space crafts that have raised personal funds reach the moon
One group has already proved to make oral immunotherapy more safer, so it provided an initial dose of omalicumab, and the second group received a placebo injection.
The first group received oral immunotherapy and received an o’clizumab’s placebo injection, and the second group provided O’Malicumab and received a placebo oral immunotherapy.
File Photo: ISTOCK
At the end of the study, the same proportion of people in each group was able to withstand at least two grams of all three foods with allergies, but far more people fell from the first group before the test.
According to the researchers, more than half of the people who left the group had an allergic reaction or other unbearable immunotherapy symptoms.
Robert Wood, a major researcher of this study, said, “This was able to compare these two treatments for many food allergies, and our study shows that Omalizumab is better than oral immunotherapy.
Studies have found that O’Malicumab is more effective than oral immunotherapy due to the high ratio of allergic reactions between immunotherapy patients.
In the UK, O’Malicumab is currently used for hives, itching red rashes and severe asthma treatment.
SKY NEWS contacted pharmaceuticals and medical product regulators and asked if it was considered for the treatment of allergies in the UK, but the information could not be confirmed as “commercially sensitive”.
